The only biomarker included in the AJCC staging system is lactate dehydrogenase (LDH), the strongest independent prognostic factor for stage IV melanoma,5 although an important increase in serum S100β levels has been associated to metastatic progression, irrespective of stage.6 Here, S100B is linked to melanoma.